MOMA Therapeutics logo

MOMA Therapeutics Funding & Investors

MOMA Therapeutics operates as a biotechnology company. MOMA Therapeutics discover the next generation of precision medicines by targeting the molecular machines that underlie human disease.

momatx.com

Total Amount Raised: $236,000,000

MOMA Therapeutics Funding Rounds

  • Series B

    $150,000,000

    Series B Investors

    Goldman Sachs Asset Management
    Third Rock Ventures
    Section 32
    Casdin Capital
    Invus
    Cormorant Asset Management
    Alexandria Venture Investments
    Rock Springs Capital
    Nextech Invest
    Creacion Ventures
    Pavilion Capital
    LifeSci Venture Partners
    Curie.Bio
  • Series A

    $86,000,000

    Series A Investors

    Third Rock Ventures
    Nextech Invest
    Casdin Capital
    Cormorant Asset Management
    Rock Springs Capital
    Alexandria Venture Investments
    Creacion Ventures
Funding info provided by Diffbot.